Pediatrix Revises Outlook for the 2008 Third and Fourth Quarters

  
    
  
  
    
      Pediatrix Medical Group, Inc., (NYSE:PDX) today announced that it is 
      revising its earnings guidance for the 2008 third quarter.
    
    
      During the 2008 third quarter, Pediatrix experienced a shift in 
      reimbursement for patient care from commercial payors to government 
      payors. In addition, same-unit neonatal intensive care unit (NICU) 
      patient volume is expected to be at the lower end of the Company’s 
      guided range, which was an anticipated decline of 1 to 4 percent.
    
    
      The Company now expects its earnings per share for the three months 
      ended September 30, 2008, will range from 81 cents to 83 cents.
    
    
      In addition, in August 2008 Pediatrix issued EPS guidance of 84 to 87 
      cents for the 2008 fourth quarter, which excluded any anesthesia 
      acquisitions completed following the issuance of that guidance. Based on 
      the recent same-unit NICU volume and payor mix trends, Pediatrix is not 
      able to confirm this guidance.
    
    
      Investor conference call
    
    
      Pediatrix Medical Group, Inc. will host an investor conference call to 
      discuss the preliminary results for the 2008 third quarter, as well as 
      other corporate developments, at 10 a.m. (EDT) today. The conference 
      call Webcast may be accessed from the Company’s 
      Website, www.pediatrix.com. 
      A telephone replay of the conference call will be available from noon 
      (EDT) today through midnight (EDT) October 15, 2008, by dialing 
      800-475-6701, access code 963245. The replay will also be available at www.pediatrix.com.
    
    
      About Pediatrix
    
    
      Pediatrix Medical Group, Inc. is the nation’s 
      leading provider of neonatal, maternal-fetal and pediatric physician 
      subspecialty services and recently expanded to include anesthesiology 
      services. Pediatrix physicians and advanced practitioners are reshaping 
      the delivery of care within the maternal-fetal, neonatal intensive care 
      and pediatric cardiology subspecialties, using evidence-based tools, 
      continuous quality initiatives and clinical research to enhance patient 
      outcomes and provide high-quality, cost-effective care. Founded in 1979, 
      its neonatal physicians provide services at more than 250 neonatal 
      intensive care units, and in many markets they collaborate with 
      affiliated maternal-fetal medicine, pediatric cardiology physician 
      subspecialists and pediatric intensivists to provide a clinical care 
      continuum. Combined, Pediatrix and its affiliated professional 
      corporations employ more than 1,200 physicians in 32 states and Puerto 
      Rico. Pediatrix is also the nation’s largest 
      provider of newborn hearing screens. Additional information is available 
      at www.pediatrix.com.
    
    
      Certain statements and information in this press release may be 
      deemed to be “forward-looking statements” 
      within the meaning of the Federal Private Securities Litigation Reform 
      Act of 1995. Forward-looking statements may include, but are not 
      limited to, statements relating to our objectives, plans and strategies, 
      and all statements (other than statements of historical facts) that 
      address activities, events or developments that we intend, expect, 
      project, believe or anticipate will or may occur in the future are 
      forward-looking statements. These statements are often characterized by 
      terminology such as “believe”, 
      “hope”, “may”, 
      “anticipate”, “should”, 
      “intend”, “plan”, 
      “will”, “expect”, 
      “estimate”, “project”, 
      “positioned”, “strategy” 
      and similar expressions, and are based on assumptions and assessments 
      made by Pediatrix’s management in light of 
      their experience and their perception of historical trends, current 
      conditions, expected future developments and other factors they believe 
      to be appropriate. Any forward-looking statements in this press release 
      are made as of the date hereof, and Pediatrix undertakes no duty to 
      update or revise any such statements, whether as a result of new 
      information, future events or otherwise. Forward-looking statements are 
      not guarantees of future performance and are subject to risks and 
      uncertainties. Important factors that could cause actual results, 
      developments, and business decisions to differ materially from 
      forward-looking statements are described in Pediatrix’s 
      most recent Annual Report on Form 10-K, including the section entitled “Risk 
      Factors”.